FDA.reportPublic FDA data

Banzel 40 MG/ML Oral Suspension

RxCUI
1092360
RxNorm name
Banzel 40 MG/ML Oral Suspension
Display name
Banzel 40 MG/ML Oral Suspension
Full name
Banzel 40 MG/ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BanzelRUFINAMIDEEisai Inc.0a3fa925-1abd-458a-bd57-4ae780a1ef2d2022-12-15Warnings, Adverse reactionsExact identifier
rxcui: 1092360

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0a3fa925-1abd-458a-bd57-4ae780a1ef2dBANZEL 40 MG in 1 mL Oral Suspension [PSN] · rufinamide 40 MG/ML Oral Suspension [Banzel] [SBD] · Banzel 40 MG per 1 ML Oral Suspension [SY] · Banzel 40 MG/ML Oral Suspension [SY]445These highlights do not include all the information needed to use BANZEL ® safely and effectively. See full prescribing information for BANZEL ® . BANZEL ® (rufinamide) film - coated t ablet, for o ral u se BANZEL ® (rufinamide) o ral s uspension Initial U.S. Approval: 200820221215